BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
71.41 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,419.226 | 2,096.039 | 1,846.275 | 1,860.455 | 1,704.048 | 1,491.212 | 1,313.646 | 1,116.854 | 889.895 | 751.04 | 548.485 | 500.723 | 441.358 | 376.267 | 324.656 | 296.493 | 121.581 | 84.209 | 25.669 | 18.641 | 12.1 | 13.919 | 11.699 | 12.326 | 6.976 | 1.2 |
| Cost of Revenue
| 577.065 | 483.669 | 470.515 | 524.272 | 359.466 | 315.264 | 241.786 | 209.62 | 152.008 | 129.764 | 95.742 | 91.83 | 84.023 | 70.285 | 65.909 | 52.509 | 18.359 | 8.74 | 2.629 | 3.953 | 0 | 0 | 0 | -6.614 | -6.094 | -0.7 |
| Gross Profit
| 1,842.161 | 1,612.37 | 1,375.76 | 1,336.183 | 1,344.582 | 1,175.948 | 1,071.86 | 907.234 | 737.887 | 621.276 | 452.743 | 408.893 | 357.335 | 305.982 | 258.747 | 243.984 | 103.222 | 75.469 | 23.04 | 14.688 | 12.1 | 13.919 | 11.699 | 18.94 | 13.07 | 1.9 |
| Gross Profit Ratio
| 0.761 | 0.769 | 0.745 | 0.718 | 0.789 | 0.789 | 0.816 | 0.812 | 0.829 | 0.827 | 0.825 | 0.817 | 0.81 | 0.813 | 0.797 | 0.823 | 0.849 | 0.896 | 0.898 | 0.788 | 1 | 1 | 1 | 1.537 | 1.874 | 1.583 |
| Reseach & Development Expenses
| 746.773 | 649.606 | 628.793 | 628.116 | 715.007 | 696.328 | 610.753 | 661.905 | 634.806 | 461.543 | 354.78 | 302.218 | 214.374 | 147.309 | 115.116 | 93.291 | 78.6 | 66.735 | 56.391 | 49.784 | 54.814 | 54.455 | 45.283 | 35.794 | 27.206 | 10.5 |
| General & Administrative Expenses
| 448.9 | 403.709 | 354.3 | 334.3 | 0 | 604.353 | 554.336 | 476.593 | 402.271 | 302.156 | 235.356 | 198.173 | 175.423 | 151.723 | 124.29 | 106.566 | 77.539 | 49.03 | 41.556 | 37.606 | 14.396 | 17.541 | 6.718 | 8.814 | 6.805 | 3.5 |
| Selling & Marketing Expenses
| 488.4 | 450.3 | 405.1 | 403.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 937.791 | 854.009 | 759.375 | 737.669 | 680.924 | 604.353 | 554.336 | 476.593 | 402.271 | 302.156 | 235.356 | 198.173 | 175.423 | 151.723 | 124.29 | 106.566 | 77.539 | 49.03 | 41.556 | 37.606 | 14.396 | 17.541 | 6.718 | 8.814 | 6.805 | 3.5 |
| Other Expenses
| -10.538 | 67.193 | 69.933 | 66.658 | 74.108 | 2.205 | 7.97 | 4.929 | -9.299 | 0.279 | 0.982 | -1.787 | 1.428 | 6.406 | 2.914 | 4.371 | 4.371 | -15.623 | -10.694 | 75.21 | 18.693 | 9.547 | 0 | 7.333 | 6.558 | 0.8 |
| Operating Expenses
| 1,684.564 | 1,570.808 | 1,458.101 | 1,432.443 | 1,470.039 | 1,349.472 | 1,211.56 | 1,111.545 | 1,019.387 | 781.667 | 608.75 | 519.108 | 389.797 | 299.032 | 242.32 | 204.228 | 160.51 | 100.142 | 87.253 | 162.6 | 87.903 | 81.543 | 52.001 | 51.941 | 40.569 | 14.8 |
| Operating Income
| 157.597 | 57.546 | -60.013 | -96.26 | -125.457 | -123.524 | -14.7 | -803.429 | -110.702 | -92.891 | -156.007 | -110.215 | -33.89 | 0.544 | 16.427 | 39.756 | -57.288 | -24.673 | -64.213 | -179.365 | -75.803 | -78.847 | -51.949 | -33.001 | -27.499 | -12.9 |
| Operating Income Ratio
| 0.065 | 0.027 | -0.033 | -0.052 | -0.074 | -0.083 | -0.011 | -0.719 | -0.124 | -0.124 | -0.284 | -0.22 | -0.077 | 0.001 | 0.051 | 0.134 | -0.471 | -0.293 | -2.502 | -9.622 | -6.265 | -5.665 | -4.44 | -2.677 | -3.942 | -10.75 |
| Total Other Income Expenses Net
| 30.966 | 92.03 | -15.337 | 53.938 | 30.646 | 51.652 | 131.679 | -594.727 | 160.682 | 66.902 | -0.167 | -3.008 | -5.75 | -22.223 | -6.857 | -6.326 | 30.525 | 19.274 | 11.838 | -102.676 | -18.693 | -20.77 | -18.98 | -7.335 | -1.673 | 0.6 |
| Income Before Tax
| 188.563 | 149.576 | -75.35 | -42.322 | -94.811 | -142.705 | -35.875 | -831.05 | -154.724 | -124.868 | -176.503 | -118.278 | -43.627 | -21.49 | 0.566 | 33.424 | -15.074 | -28.533 | -74.27 | -187.443 | -75.798 | -77.461 | -70.929 | -40.336 | -29.172 | -12.3 |
| Income Before Tax Ratio
| 0.078 | 0.071 | -0.041 | -0.023 | -0.056 | -0.096 | -0.027 | -0.744 | -0.174 | -0.166 | -0.322 | -0.236 | -0.099 | -0.057 | 0.002 | 0.113 | -0.124 | -0.339 | -2.893 | -10.055 | -6.264 | -5.565 | -6.063 | -3.272 | -4.182 | -10.25 |
| Income Tax Expense
| 20.918 | 8.015 | -11.27 | -901.422 | -70.963 | -65.494 | 81.167 | -200.84 | 17.075 | 9.101 | -0.15 | -3.931 | 10.209 | -227.309 | 1.054 | 2.593 | 0.729 | 23.134 | 21.895 | 36.559 | -0.005 | 9.837 | 19.971 | 4.363 | 0.573 | -0.6 |
| Net Income
| 167.645 | 141.561 | -64.08 | 854.029 | -23.848 | -77.211 | -117.042 | -630.21 | -171.799 | -133.969 | -176.353 | -114.347 | -53.836 | 205.819 | -0.488 | 30.831 | -15.803 | -28.533 | -74.27 | -187.443 | -75.798 | -77.461 | -67.606 | -37.364 | -28.072 | -12.3 |
| Net Income Ratio
| 0.069 | 0.068 | -0.035 | 0.459 | -0.014 | -0.052 | -0.089 | -0.564 | -0.193 | -0.178 | -0.322 | -0.228 | -0.122 | 0.547 | -0.002 | 0.104 | -0.13 | -0.339 | -2.893 | -10.055 | -6.264 | -5.565 | -5.779 | -3.031 | -4.024 | -10.25 |
| EPS
| 0.89 | 0.76 | -0.35 | 4.75 | -0.13 | -0.44 | -0.67 | -3.8 | -1.07 | -0.92 | -1.28 | -0.95 | -0.48 | 1.99 | -0.005 | 0.31 | -0.16 | -0.34 | -1.08 | -2.91 | -1.22 | -1.45 | -1.65 | -1.04 | -0.94 | -0.55 |
| EPS Diluted
| 0.88 | 0.75 | -0.35 | 4.53 | -0.13 | -0.44 | -0.67 | -3.79 | -1.07 | -0.92 | -1.28 | -0.95 | -0.48 | 1.73 | -0.005 | 0.29 | -0.16 | -0.34 | -1.08 | -2.91 | -1.22 | -1.45 | -1.65 | -1.04 | -0.94 | -0.55 |
| EBITDA
| 261.983 | 159.515 | 48.026 | -5.85 | -22.243 | -100.25 | -71.697 | -192.433 | -287.278 | -137.758 | -118.792 | -91.922 | -31.954 | 8.071 | 21.833 | 54.189 | -52.917 | -12.715 | -54.138 | -34.929 | -47.668 | -38.35 | -21.651 | -18.333 | -19.268 | -12.7 |
| EBITDA Ratio
| 0.108 | 0.076 | 0.026 | -0.003 | -0.013 | -0.067 | -0.055 | -0.172 | -0.323 | -0.183 | -0.217 | -0.184 | -0.072 | 0.021 | 0.067 | 0.183 | -0.435 | -0.151 | -2.109 | -1.874 | -3.94 | -2.755 | -1.851 | -1.487 | -2.762 | -10.583 |